1. Amgen’s drug Parsabiv is intended to treat secondary hyperhythroidism in patients with chronic kidney disease who are undergoing dialysis.
2. The Seeker System is a screening test designed to detect four metabolic disorders in newborns.
3. Bristol-Myers Squibb’s best-selling cancer drug Opdivo can now be used to treat urothelial carcinoma — the most common type of bladder cancer.
4. Emflaza is intended to treat Duchenne’s muscular dystrophy, a rare degenerative condition that causes muscle weakness, loss of movement and eventually death.
More articles on supply chain:
Supply chain tip of the week: 9 questions to test your inventory management IQ
10 statistics on drug, device recalls in Q4
6 quotes from Pfizer CEO on Trump, drug prices and more
